DIAGENS-B (02526) is scheduled to list on the Hong Kong exchange on March 30 (next Monday). As of the latest update, unlisted trading indicated a price of HK$185.2, representing an increase of 87.07% compared to the offer price of HK$99. With each lot consisting of 50 shares, and excluding handling fees, this translates to a profit of HK$4,310 per lot.